Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2014, Vol. 19 ›› Issue (5): 503-506.

Previous Articles     Next Articles

Effects of Liuweidihuang Formula (LWDHF) on ET,TXA2,PGI2 and protecting the endotheliocytes in the blood plasma of rats with hyperlipidemia

YU Li-zhen1, BIAN Hui-ming2 , YU Jing-hua2   

  1. 1Department of Pharmacy, Wannan Medical College, Wuhu 241002,Anhui,China;
    2Nanjing University of Traditional Chinese Medicine, Nanjing 210029,Jiangsu,China
  • Received:2013-05-24 Revised:2014-04-28 Online:2014-05-26 Published:2014-06-05

Abstract: AIM: To observe the effects of Liuweidihuang Formula (LWDHF) on ET,TXA2,PGI2 and protecting the endotheliocytes in the blood plasma of rats with hyperlipidemia.METHODS: The hyperlipidemia rat model was established by feeding high cholesterol diet. Circulating endothelial cells (CEC) in peripheral blood and the pathological change of aortas were detected. Meanwhile the levels of plasma Endothelin (ET) , prostaglandin I2 (PGI2),thromboxane A2 (TXA2) were measured.RESULTS: LWDHF could decrease CEC in peripheral blood and the injury of aortic endothelial cells in hyperlipidemia rats,and the levels of plasma ET, TXA2 were decreased, the level of PGI2 was increased.CONCLUSION: LWDHF might protect vascular endothelial cells of hyperlipidemia rat. The mechanism may relate to improve the secretion function of endothelial cell.

Key words: Liuweidihuang Formula, endothelin (ET), thromboxane(TXA2), prostaglandin (PGI2), vascular endothelial cell

CLC Number: